SI-BONE, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SI-BONE, Inc. on November 6, 2025. The filing primarily addresses corporate governance changes and references the announcement of financial results for the quarter ended September 30, 2025, which was issued via a press release on November 10, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached Press Release (Exhibit 99.1) and are not detailed in the body of this 8-K report.
Material Changes and Corporate Events
- Board Resignation: Daniel Wolf resigned from the Board of Directors and all committees on November 6, 2025. The resignation was not due to any disagreement with the Company.
- Board Restructuring: The Board size was reduced from nine to eight directors. Thomas A. West was appointed to the Audit Committee.
- Consulting Agreement: The Company entered into a 12-month consulting agreement with Mr. Wolf to support marketing, strategy, and business development.
- Equity Acceleration: As part of the agreement, 8,675 restricted stock units (RSUs) granted to Mr. Wolf on June 5, 2025, were fully accelerated and vested as of November 6, 2025.
- Compensation: Mr. Wolf will receive cash compensation at an hourly rate defined in statements of work.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, or risk factors. It notes that the financial results referenced in Item 2.02 are not deemed "filed" for purposes of Section 18 of the Exchange Act and are not incorporated by reference into other filings.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific Q3 2025 financial results, as they are not included in this text.
- Verify the terms of the Consulting Agreement with Daniel Wolf, including the hourly rate and scope of work, which will be filed in the upcoming Form 10-Q.
- Confirm the impact of the RSU acceleration on the company's share count and dilution.
- Monitor the composition of the Audit Committee following the appointment of Thomas A. West.